186 related articles for article (PubMed ID: 1604572)
1. The effect of ultraviolet B-irradiated leukocyte transfusions in intestinal transplantation.
Xiao F; Foster PF; Sankary HN; Kociss K; Templeton AC; Williams JW
Transplant Proc; 1992 Jun; 24(3):1167-8. PubMed ID: 1604572
[No Abstract] [Full Text] [Related]
2. Different response of intestinal and cardiac allografts to pretreatment with UV-B irradiated donor-specific leukocytes (DL) or DL alone.
Gundlach M; Oluwole SF; Pohland CC; Broelsch CE; Hardy MA
Transplant Proc; 1996 Oct; 28(5):2482-3. PubMed ID: 8907913
[No Abstract] [Full Text] [Related]
3. Allograft ultraviolet-B irradiation in rat small intestinal transplantation.
Foster PF; Xiao F; Kociss K; Chong AS; Sankary HN; McChesney L; Cohn S; Williams JW
Transplant Proc; 1994 Jun; 26(3):1624-5. PubMed ID: 8030062
[No Abstract] [Full Text] [Related]
4. Amelioration of graft-versus-host disease following bowel transplantation with recipient specific leukocyte transfusion.
Xiao F; Foster PF; Sankary HN; Kociss K; Williams JW
Transplant Proc; 1992 Jun; 24(3):1192-3. PubMed ID: 1604582
[No Abstract] [Full Text] [Related]
5. Small bowel transplantation in the rat: the effect of donor-specific transfusion 24 hours pretransplant and cyclosporine.
Fecteau A; Tchervenkov J; Guttman FM; Rosenmann E
Transplant Proc; 1992 Jun; 24(3):1166. PubMed ID: 1604571
[No Abstract] [Full Text] [Related]
6. The role of ultraviolet B-irradiated leukocyte transfusions and cyclosporine in intestinal transplantation.
Xiao F; Foster PF; Sankary HN; Templeton AC; Kociss K; Williams JW
Transplantation; 1992 Jul; 54(1):32-7. PubMed ID: 1631941
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment with irradiation and donor-specific transfusion prolongs survival in small intestinal transplantation.
Greenstein SM; Sun SC; Senitzer D; Schechner RS; Tellis VA
Transplant Proc; 1993 Feb; 25(1 Pt 1):490-1. PubMed ID: 8438391
[No Abstract] [Full Text] [Related]
8. The effect of blood transfusions on graft-versus-host disease in small intestine transplantation in rats.
Murr MM; Corry RJ
Transplant Proc; 1992 Jun; 24(3):1187-8. PubMed ID: 1604580
[No Abstract] [Full Text] [Related]
9. Intraportal injection of specific allogeneic cells can prolong neonatal intestinal free graft survival.
Lee SK; Perez-Atayde A; Takeda T; Vacanti JP; Lund DP
Transplant Proc; 1994 Jun; 26(3):1579-80. PubMed ID: 8030044
[No Abstract] [Full Text] [Related]
10. Fulminant graft-versus-host disease after FK 506 treatment in fully allogeneic small bowel transplantation.
de Bruin RW; HogenEsch H; Heineman E; Jeekel J; Marquet RL
Transplant Proc; 1991 Dec; 23(6):3257-9. PubMed ID: 1721429
[No Abstract] [Full Text] [Related]
11. Importance of lymphoid tissue for survival of small bowel allografts.
Pirenne J; Williams JG; Kim S; Fryer J; Benedetti E; Hakim NS; Médot M; Najarian JS; Gruessner RW; Dunn DL
Transplant Proc; 1995 Feb; 27(1):1359-60. PubMed ID: 7878911
[No Abstract] [Full Text] [Related]
12. Lethal graft-vs-host disease after cyclosporine therapy in recipients of sensitized small bowel allografts.
Langrehr JM; Markus PM; Lee TK; Müller AR; Banner B; Lee KK; Schraut WH
Transplant Proc; 1992 Jun; 24(3):1138. PubMed ID: 1604556
[No Abstract] [Full Text] [Related]
13. Impact of different forms of recipient antigen and different routes of antigen administration in donor pretreatment for preventing graft-versus-host disease in rat small bowel transplantation.
He G; Wang M; Xu H; Tian L; Yu J; Stepkowski SM; Kahan BD
Transplant Proc; 1996 Oct; 28(5):2469. PubMed ID: 8907906
[No Abstract] [Full Text] [Related]
14. The effect of rapamycin on orthotopic small bowel transplantation in the rat.
Chen H; Wu J; Xu D; Aboujaoude M; Stepkowski S; Kahan B; Daloze P
Transplant Proc; 1992 Jun; 24(3):1157-8. PubMed ID: 1604567
[No Abstract] [Full Text] [Related]
15. Use of spleen transplantation and cyclosporine A treatment to ameliorate survival after small bowel transplantation.
Pirenne J; D'Silva M; Jacquet N
Transplant Proc; 1993 Feb; 25(1 Pt 2):1206. PubMed ID: 8442087
[No Abstract] [Full Text] [Related]
16. Immunosuppression by combined liver transplantation in the rat mechanisms of graft acceptance and regulation of graft-vs-host disease.
Kobayashi E; Kamada N; Enosawa S; Toyama N; Lord R; Stamatiou S; Delriviere L; Miyata M
Transplant Proc; 1994 Jun; 26(3):1575-7. PubMed ID: 8030042
[No Abstract] [Full Text] [Related]
17. Donor intrathymic injection with recipient splenocytes allows indefinite survival following small bowel transplantation in a rat graft-vs-host disease model.
Blakely ML; Shaffer D; Ohzato H; Gottschalk R; Van der Werf WJ; Monaco AP
Transplant Proc; 1994 Jun; 26(3):1582. PubMed ID: 8030046
[No Abstract] [Full Text] [Related]
18. Reversal of experimental small bowel transplantation rejection with cyclosporine A.
Liu Q; Yang R; Grosfeld JL; Collins MH; Pescovitz MD
Transplant Proc; 1996 Oct; 28(5):2508-9. PubMed ID: 8907925
[No Abstract] [Full Text] [Related]
19. Suppressive effects of serum from liver-transplanted rats against graft-versus-host disease.
Enoki T; Kamada N; Schlect D; Buckley M; Goto S; Hara Y; Shimizu Y; Vari F; Morita N; Esato K
Transplant Proc; 1996 Jun; 28(3):1769-70. PubMed ID: 8658875
[No Abstract] [Full Text] [Related]
20. Effect of short-term immunosuppressive therapy with FK 506 or CyA on the donor in small intestine allotransplantation in rats.
Santiago SF; Fukuzawa M; Azuma T; Okada A
Transplant Proc; 1992 Jun; 24(3):1189. PubMed ID: 1376520
[No Abstract] [Full Text] [Related]
[Next] [New Search]
